GPIQ vs TDAQ: Which Is the Better Pick in 2026?

Overview

Both GPIQ and TDAQ are equity ETFs that overlay call options on Nasdaq-100 exposure to generate monthly income while holding a growth-oriented tech portfolio. GPIQ invests directly in Nasdaq-100 constituents and sells calls against them; TDAQ tracks the Invesco QQQ Trust (which also mirrors the Nasdaq-100) but uses a more aggressive income overlay. The key distinction is yield generation strategy: GPIQ targets a 10.90% distribution rate through standard covered calls, while TDAQ pursues 17.32% by employing zero-days-to-expiration (0DTE) options that reset daily.

How they differ

TDAQ's 0DTE strategy is the fundamental difference—it sells calls expiring the same day, rolling positions constantly to capture daily volatility decay. GPIQ uses traditional covered calls with longer tenor, accepting lower income but also lower turnover. Second, the yield gap is material: TDAQ distributes 17.32% annually versus GPIQ's 10.90%, a 640-basis-point spread that directly reflects the higher friction and leverage implicit in daily resets. Third, cost and scale diverge sharply. GPIQ charges 0.29% in fees and manages $4.62B in assets, while TDAQ costs 0.83% and holds only $227M—a 54-basis-point fee difference plus a 20-fold AUM gap that implies less liquidity and operational maturity. TDAQ also carries higher beta at 1.287 versus GPIQ's 1.0964, indicating more pronounced upside capture and downside swing.

Who each is best for

GPIQ: Fits investors seeking monthly Nasdaq-100 income without extreme yield drag—those comfortable with a double-digit distribution but unwilling to sacrifice capital stability or accept daily options churn. Works well for income-focused allocations that value fund size and operational track record.

TDAQ: Designed for investors with high current-income requirements and tolerance for NAV volatility who understand that 0DTE overlays trade upside capping for maximum monthly cash flow and are comfortable with newer, smaller vehicles and the operational complexity of daily rolls.

Key risks to know

• NAV erosion at yields above 15%: TDAQ's 17.32% distribution rate likely includes return-of-capital or option premium that outpaces underlying Nasdaq-100 returns; this dynamic favors income today at the expense of share price over time. GPIQ's lower yield faces less acute NAV pressure but remains subject to the same structural mechanic.

• 0DTE liquidity and slippage risk: TDAQ's daily option rolls expose the fund to intraday liquidity gaps, wider bid-ask spreads on short-dated calls, and the risk that closing and resetting positions costs more than implied by published fees, particularly in volatile or low-volume trading windows.

• Call capping and capital appreciation loss: Both funds cap upside through call sales; TDAQ's 0DTE resets daily but still limits rally participation on any single day, while GPIQ's longer-dated calls cap upside over a wider window. In strong bull markets, both underperform unhedged Nasdaq-100 exposure.

• Operational and regulatory risk for emerging strategy: TDAQ launched in September 2025 and is untested through a full market cycle; the 0DTE overlay is relatively new in the ETF wrapper and carries execution, compliance, and potential regulatory scrutiny risk that a larger, longer-tenured fund like GPIQ avoids.

• Beta and volatility amplification: TDAQ's 1.287 beta compared to GPIQ's 1.0964 means tech sector drawdowns hit harder; combined with the constant rebalancing friction of 0DTE rolls, downturns may be felt asymmetrically.

Bottom line

If you prioritize proven scale, lower fees, and a measured income strategy with less operational complexity, GPIQ's 10.90% yield and $4.62B AUM offer a more established approach. If you're willing to accept a newer fund, higher fees, higher beta, and daily options churn to pursue an extra 640 basis points of annual income, TDAQ's 0DTE overlay delivers that yield—at the cost of tighter upside capping and meaningful NAV erosion risk above 15% payouts. Past performance does not guarantee future results.